EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 233 (2026) BIO Web Conf., 233 (2026) 01022 References
Open Access
Issue
BIO Web Conf.
Volume 233, 2026
9th International Conference on Advances in Biosciences and Biotechnology: Emerging Innovations in Biomedical and Bioengineering Sciences (ICABB 2026)
Article Number 01022
Number of page(s) 14
Section Biomedical and Health Innovations
DOI https://doi.org/10.1051/bioconf/202623301022
Published online 23 April 2026
  • Klupa T, Skupien J, Malecki MT. Monogenic models: what have the single gene disorders taught us? Curr Diab Rep. 2012 Dec;12(6):659–66. doi: 10.1007/s11892-012-0325-0. [Google Scholar]
  • Condo I. Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies. Int J Mol Sci. 2022 Jun 10;23(12):6525. doi: 10.3390/ijms23126525. [Google Scholar]
  • Vinksel M, Writzl K, Maver A, Peterlin B. Improving diagnostics of rare genetic diseases with NGS approaches. J Community Genet. 2021 Apr;12(2):247–256. doi: 10.1007/s12687-020-00500-5. [Google Scholar]
  • Komachali SR, Siahpoosh Z, Rafiee S. Novel mutations of PCCA and PCCB genes found by whole-exome sequencing related to propionic acidemia patients. European Journal of Biological Research 12(4):294–306 (2022). doi: 10.5281/zenodo.7374273 [Google Scholar]
  • Liu J, Wang X, Huang D, Qi Y, Xu L, Shao Y. A novel ABCD1 gene mutation causes adrenomyeloneuropathy presenting with spastic paraplegia: A case report. Medicine 103(16):e37874 (2024). doi: 10.1097/MD.0000000000037874 [Google Scholar]
  • Zuo X, Chen Z. From gene to therapy: a review of deciphering the role of ABCD1 in combating X-Linked adrenoleukodystrophy. Lipids Health Dis 23, 369 (2024). doi: 10.1186/s12944-024-02361-0 [Google Scholar]
  • Palakuzhiyil SV, Christopher R, Chandra SR. Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy. World J Biol Chem. 2020 Nov 27;11(3):99–111. doi: 10.4331/wjbc.v11.i3.99. [Google Scholar]
  • Ma CY, Li C, Zhou X, Zhang Z, Jiang H, Liu H, Chen HJ, Tse HF, Liao C, Lian Q. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies. Front Genome Ed. 2021 Sep 21;143:112214. doi: 10.1016/j.biopha.2021.112214 [Google Scholar]
  • Lin L, Guo C, Jin H, et al. Integrative multi-omics approach using random forest and artificial neural network models for early diagnosis and immune infiltration characterization in ischemic stroke. Front Neurol. 2024 Dec 4;15:1475582. doi: 10.3389/fneur.2024.1475582. [Google Scholar]
  • Blanco-Gonzalez A, Cabezon A, Seco-Gonzalez A, et al. The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies. Pharmaceuticals (Basel). 2023 Jun 18;16(6):891. doi: 10.3390/ph16060891. [Google Scholar]
  • Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 7, 51 (2012). doi: 10.1186/1750-1172-751 [Google Scholar]
  • Rajakumar HK, et al. Childhood Cerebral Adrenoleukodystrophy: Case Report and Literature Review Advocating for Newborn Screening. Degener Neurol Neuromuscul Dis. 2024 Jun 17;14:75–83. doi: 10.2147/DNND.S442985. [Google Scholar]
  • Bonkowsky JL, Healey B, Sacks NC, et al. Burden of illness and mortality in men with Adrenomyeloneuropathy: a retrospective cohort study. Orphanet J Rare Dis 19, 270 (2024). doi: 10.1186/s13023-024-03276-w [Google Scholar]
  • Wang QH, Wang YY, Wang J, et al. Easily misdiagnosed X-linked adrenoleukodystrophy. Ital J Pediatr 50, 124 (2024). doi: 10.1186/s13052-024-01669-y [Google Scholar]
  • Lauer A, Speroni SL, Choi M, et al. Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy. Nat Commun 14, 1900 (2023). doi: 10.1038/s41467023-37262-w [Google Scholar]
  • Rattay TW, Rautenberg M, Sohn AS, et al. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy. Sci Rep 10, 15093 (2020). doi:10.1038/s41598-020-71248-8 [Google Scholar]
  • Liberato AP, Mallack EJ, Aziz-Bose R, et al. MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy. Neurology. 2019 Apr 9;92(15):e1698–e1708. doi: 10.1212/WNL.0000000000007294. [Google Scholar]
  • Choon YW, Choon YF, Nasarudin NA, et al. Artificial intelligence and database for NGS-based diagnosis in rare disease. Front Genet. 2024 Jan 25;14:1258083. doi: 10.3389/fgene.2023.1258083. [Google Scholar]
  • Paquette M, Bernard S, Cariou B, et al. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events. Arterioscler Thromb Vasc Biol. 2021 Oct;41(10):2632–2640. doi: 10.1161/ATVBAHA.121.316106. [Google Scholar]
  • Machado TF, Neto FDCB, Goncalves MS, Barbosa CG, Barreto ME. Exploring machine learning algorithms in sickle cell disease patient data: A systematic review. PLoS One. 2024 Nov 11;19(11):e0313315. doi: 10.1371/journal.pone.0313315. [Google Scholar]
  • Pan Y, Liu J, Cai Y, et al. Fundus image classification using Inception V3 and ResNet-50 for the early diagnostics of fundus diseases. Front Physiol. 2023 Feb 15;14:1126780. doi: 10.3389/fphys.2023.1126780. [Google Scholar]
  • Myers KA, Rho JM, Wei XC. Teaching NeuroImages: MRI findings in X-linked adrenoleukodystrophy. Neurology. 2015 Oct 27;85(17):e132–3. doi: 10.1212/WNL.0000000000002063. [Google Scholar]
  • Ferrante M, Rinaldi L, Botta F, et al. Application of nnU-Net for Automatic Segmentation of Lung Lesions on CT Images and Its Implication for Radiomic Models. J Clin Med 11(24):7334 (2022). doi: 10.3390/jcm11247334 [Google Scholar]
  • Yang M, Zheng Y, Xie Z, et al. A deep learning model for diagnosing dystrophinopathies on thigh muscle MRI images. BMC Neurol 21, 13 (2021). doi: 10.1186/s12883-020-02036-0 [Google Scholar]
  • Parad RB, Kaler SG, Mauceli E, et al. Targeted next generation sequencing for newborn screening of Menkes disease. Mol Genet Metab Rep. 2020 Jul 21;24:100625. doi: 10.1016/j.ymgmr.2020.100625. [Google Scholar]
  • Pyo SJ, Kim H, Kim IS, et al. Quantitative Gait Analysis in Patients with Huntington’s Disease. J Mov Disord. 2017 Sep;10(3):140–144. doi: 10.14802/jmd.17041. [Google Scholar]
  • Karim A, Su Z, West PK, et al. Molecular Classification and Interpretation of Amyotrophic Lateral Sclerosis Using Deep Convolution Neural Networks and Shapley Values. Genes (Basel). 2021 Oct 30;12(11):1754. doi: 10.3390/genes12111754. [Google Scholar]
  • Amprimo G, Masi G, Olmo G, Ferraris C. Deep Learning for hand tracking in Parkinson’s Disease video-based assessment. Artif Intell Med. 2024 Aug;154:102914. doi: 10.1016/j.artmed.2024.102914. [Google Scholar]
  • Li S, Feng Z, Xiao C, Wu Y, Ye W. The Establishment of Hypertrophic Cardiomyopathy Diagnosis Model via Artificial Neural Network and Random Decision Forest Method. Mediators Inflamm. 2022 Sep 15;2022:2024974. doi: 10.1155/2022/2024974. [Google Scholar]
  • Abe S, Tago S, Yokoyama K, et al. Explainable AI for Estimating Pathogenicity of Genetic Variants Using LargeScale Knowledge Graphs. Cancers 15(4):1118 (2023). doi: 10.3390/cancers15041118 [Google Scholar]
  • Li C, Zhi D, Wang K, et al. MetaRNN: differentiating rare pathogenic and rare benign missense SNVs and InDels using deep learning. Genome Med 14, 115 (2022). doi: 10.1186/s13073-022-01120-z [Google Scholar]
  • Poplin R, Chang PC, Alexander D, et al. A universal SNP and small-indel variant caller using deep neural networks. Nat Biotechnol 36, 983–987 (2018). doi: 10.1038/nbt.4235 [Google Scholar]
  • de Sainte Agathe JM, Filser M, Isidor B, et al. SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation. Hum Genomics 17, 7 (2023). doi: 10.1186/s40246-023-00451-1 [Google Scholar]
  • Pejaver V, Urresti J, Lugo-Martinez J, et al. Inferring the molecular and phenotypic impact of amino acid variants with MutPred2. Nat Commun 11, 5918 (2020). doi: 10.1038/s41467-020-19669-x [Google Scholar]
  • Monti M, Fiorentino J, Milanetti E, Gosti G, Tartaglia GG. Prediction of Time Series Gene Expression and Structural Analysis of Gene Regulatory Networks Using Recurrent Neural Networks. Entropy 24(2):141 (2022). doi: 10.3390/e24020141 [Google Scholar]
  • Jia J, Wang R, An Z, et al. RDAD: A Machine Learning System to Support Phenotype-Based Rare Disease Diagnosis. Front Genet. 2018 Dec 4;9:587. doi: 10.3389/fgene.2018.00587. [Google Scholar]
  • Yoo B, Birgmeier J, Bernstein JA, et al. InpherNet accelerates monogenic disease diagnosis using patients’ candidate genes’ neighbors. Genet Med 23, 1984–1992 (2021). doi: 10.1038/s41436-021-01238-2 [Google Scholar]
  • Dingemans AJM, Hinne M, Truijen KMG, et al. PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework. Nat Genet. 2023 Sep;55(9):1598–1607. doi: 10.1038/s41588-023-01469-w. [Google Scholar]
  • Prinzi J, Pasquali M, Hobert JA, et al. Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective. Int J Neonatal Screening 9(4):64 (2023). doi: 10.3390/ijns9040064 [Google Scholar]
  • Aryal S, Sharma S, Poudel S, Sharma S. Role of MRI in X-linked adrenoleukodystrophy-A case report. Radiol Case Rep. 2022 Sep 18;17(11):4403–4407. doi: 10.1016/j.radcr.2022.08.052. [Google Scholar]
  • Chen YT, Huang YC, Chen HL, et al. Automatic segmentation of white matter lesions on multi-parametric MRI: convolutional neural network versus vision transformer. BMC Neurol 25, 5 (2025). doi: 10.1186/s12883-02404010-6 [Google Scholar]
  • Douglas GM, Maffei VJ, Zaneveld JR, et al. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020 Jun;38(6):685–688. doi: 10.1038/s41587-020-0548-6. [Google Scholar]
  • Sirasani JP, Gardner C, Jung G, Lee H, Ahn TH. Bioinformatic approaches to blood and tissue microbiome analyses: challenges and perspectives. Briefings in Bioinformatics 26(2):bbaf176 (2025). doi: 10.1093/bib/bbaf176 [Google Scholar]
  • Hong J, Lee D, Hwang A, et al. Rare disease genomics and precision medicine. Genomics Inform. 2024 Dec 3;22(1):28. doi: 10.1186/s44342-024-00032-1. [Google Scholar]
  • Du Y, Xie J, Chang W, Han Y, Cao G. Genome-wide association studies: inherent limitations and future challenges. Front Med. 2012 Dec;6(4):444–50. doi: 10.1007/s11684-012-0225-3. [Google Scholar]
  • Chen R, Petrazzini BO, Duffy A, et al. Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease. Genome Biol. 2025 Mar 10;26(1):50. doi: 10.1186/s13059-025-03518-5. [Google Scholar]
  • Lin Q, Tam PK, Tang CS. Artificial intelligence-based approaches for the detection and prioritization of genomic mutations in congenital surgical diseases. Front Pediatr. 2023 Aug 1;11:1203289. doi: 10.3389/fped.2023.1203289. [Google Scholar]
  • Ballard J, Wang Z, Li W, et al. Deep learning-based approaches for multi-omics data integration and analysis. BioData Mining 17, 38 (2024). doi: 10.1186/s13040-024-00391-z [Google Scholar]
  • Wu Y, Xie L. AI-driven multi-omics integration for multi-scale predictive modeling of genotypeenvironmentphenotype relationships. Comput Struct Biotechnol J 27:265–277 (2025). doi: 10.1016/j.csbj.2024.12.030. [Google Scholar]
  • van Hilten A, Kushner SA, Kayser M, et al. GenNet framework: interpretable deep learning for predicting phenotypes from genetic data. Commun Biol 4, 1094 (2021). doi: 10.1038/s42003-021-02622-z [Google Scholar]
  • van Hilten A, van Rooij J, BIOS consortium, et al. Phenotype prediction using biologically interpretable neural networks on multi-cohort multi-omics data. npj Syst Biol Appl 10, 81 (2024). doi: 10.1038/s41540-024-00405-w [Google Scholar]
  • Abdelwahab O, Torkamaneh D. Artificial intelligence in variant calling: a review. Front Bioinform. 2025 Apr 23;5:1574359. doi: 10.3389/fbinf.2025.1574359. [Google Scholar]
  • Sharma A, Lysenko A, Jia S, et al. Advances in AI and machine learning for predictive medicine. J Hum Genet 69, 487–497 (2024). doi: 10.1038/s10038-024-01231-y [Google Scholar]
  • De La Vega FM, Chowdhury S, Moore B, et al. Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases. Genome Med 13, 153 (2021). doi: 10.1186/s13073-021-00965-0 [Google Scholar]
  • Masood F, Khan WU, Ullah K, et al. A Hybrid CNN-LSTM Random Forest Model for Dysgraphia Classification from Hand-Written Characters with Uniform/Normal Distribution. Applied Sciences 13(7):4275 (2023). doi: 10.3390/app13074275 [Google Scholar]
  • Taye MM. Theoretical Understanding of Convolutional Neural Network: Concepts, Architectures, Applications, Future Directions. Computation 11(3):52 (2023). doi: 10.3390/computation11030052 [Google Scholar]
  • Razali MN, Arbaiy N, Lin PC, Ismail S. Optimizing Multiclass Classification Using Convolutional Neural Networks with Class Weights and Early Stopping for Imbalanced Datasets. Electronics 14(4):705 (2025). doi: 10.3390/electronics14040705 [Google Scholar]
  • Song Z, Shi Z, Yan X, et al. An Improved Weighted Cross-Entropy-Based Convolutional Neural Network for Auxiliary Diagnosis of Pneumonia. Electronics 13(15):2929 (2024). doi: 10.3390/electronics13152929 [Google Scholar]
  • Stephan J, Stegle O, Beyer A. A random forest approach to capture genetic effects in the presence of population structure. Nat Commun 6, 7432 (2015). doi: 10.1038/ncomms8432 [Google Scholar]
  • Lebedev AV, Westman E, Van Westen GJ, et al. Random Forest ensembles for detection and prediction of Alzheimer’s disease with a good between-cohort robustness. Neuroimage Clin. 2014 Aug 28;6:115–25. doi: 10.1016/j.nicl.2014.08.023. [Google Scholar]
  • Mienye ID, Swart TG, Obaido G. Recurrent Neural Networks: A Comprehensive Review of Architectures, Variants, and Applications. Information 15(9):517 (2024). doi: 10.3390/info15090517 [Google Scholar]
  • Nguyen HT, Dang Le KD, Pham NH, Le Hoang Tran C. Deep bidirectional LSTM for disease classification supporting hospital admission based on pre-diagnosis: a case study in Vietnam. Int J Inf Technol. 2023 May 15:1–9. doi: 10.1007/s41870-023-01283-x. [Google Scholar]
  • Ouanes K, Farhah N. Effectiveness of Artificial Intelligence (AI) in Clinical Decision Support Systems and Care Delivery. J Med Syst. 2024 Aug 12;48(1):74. doi: 10.1007/s10916-024-02098-4. [Google Scholar]
  • Gangwal A, Lavecchia A. AI-Driven Drug Discovery for Rare Diseases. J Chem Inf Model. 2025 Mar 10;65(5):2214–2231. doi: 10.1021/acs.jcim.4c01966. [Google Scholar]
  • McGowan E, Sanjak J, Mathe EA, et al. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma. Orphanet J Rare Dis 18, 301 (2023). doi: 10.1186/s13023-023-02876-2 [Google Scholar]
  • Kemp S, Wanders RJ. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC halftransporters and the complicated route to treatment. Mol Genet Metab. 2007 Mar;90(3):268–76. doi: 10.1016/j.ymgme.2006.10.001. [Google Scholar]
  • Wu Z, Ramsundar B, Feinberg EN, et al. MoleculeNet: a benchmark for molecular machine learning. Chem Sci 9(2):513–530 (2017). doi: 10.1039/c7sc02664a [Google Scholar]
  • Ozturk H, Ozgur A, Ozkirimli E. DeepDTA: deep drug-target binding affinity prediction. Bioinformatics 34(17):i821–i829 (2018). doi: 10.1093/bioinformatics/bty593 [Google Scholar]
  • Zeng Y, Chen X, Peng D, Zhang L, Huang H. Multi-scaled self-attention for drug-target interaction prediction based on multi-granularity representation. BMC Bioinformatics. 2022 Aug 3;23(1):314. doi: 10.1186/s12859-022-04857x. [Google Scholar]
  • Knox C, Wilson M, Klinger CM, et al. DrugBank 6.0: The DrugBank Knowledgebase for 2024. Nucleic Acids Research 52(D1):D1265–D1275 (2024). doi: 10.1093/nar/gkad976 [Google Scholar]
  • Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35(Database issue):D198–201 (2007). doi: 10.1093/nar/gkl999 [Google Scholar]
  • Gaulton A, Bellis LJ, Bento AP, et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Research 40(D1):D1100–D1107 (2012). doi: 10.1093/nar/gkr777 [Google Scholar]
  • Kleiboeker B, Lodhi IJ. Peroxisomal regulation of energy homeostasis: Effect on obesity and related metabolic disorders. Mol Metab. 2022 Nov;65:101577. doi: 10.1016/j.molmet.2022.101577. [Google Scholar]
  • Fourcade S, Ferrer I, Pujol A. Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration. Free Radical Biology and Medicine 88:18–29 (2015). doi: 10.1016/j.freeradbiomed.2015.05.041 [Google Scholar]
  • Manor J, Chung H, Bhagwat PK, Wangler MF. ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models. J Neuroscience Research 99(12):3170–3181 (2021). doi: 10.1002/jnr.24953 [Google Scholar]
  • Liu H, Zhu Y, Li M, Gu Z. Precise genome editing with base editors. Med Rev (2021). 2023 Feb 22;3(1):75–84. doi: 10.1515/mr-2022-0044 [Google Scholar]
  • Niu R, Peng J, Zhang Z, Shang X. R-CRISPR: A Deep Learning Network to Predict Off-Target Activities with Mismatch, Insertion and Deletion in CRISPR-Cas9 System. Genes 12(12):1878 (2021). doi: 10.3390/genes12121878 [Google Scholar]
  • Chen Q, Chuai G, Zhang H, et al. Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints. Nat Commun 14, 7521 (2023). doi: 10.1038/s41467-023-42695-4 [Google Scholar]
  • Cabre-Romans JJ, Cuella-Martin R. CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders. Front Genome Ed. 2025 Apr 2;7:1553590. doi: 10.3389/fgeed.2025.1553590. [Google Scholar]
  • Hong SA, Seo JH, Wi S, et al. In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment. Mol Ther. 2022 Jan 5;30(1):119–129. doi: 10.1016/j.ymthe.2021.05.022. [Google Scholar]
  • Bhat AA, Nisar S, Mukherjee S, et al. Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics. J Transl Med. 2022 Nov 18;20(1):534. doi: 10.1186/s12967-022-03765-1. [Google Scholar]
  • Strianese O, Rizzo F, Ciccarelli M, et al. Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease. Genes (Basel). 2020 Jul 6;11(7):747. doi: 10.3390/genes11070747. [Google Scholar]
  • Tong L, Shi W, Isgut M, et al. Integrating Multi-Omics Data With EHR for Precision Medicine Using Advanced Artificial Intelligence. IEEE Rev Biomed Eng. 2024;17:80–97. doi: 10.1109/RBME.2023.3324264. [Google Scholar]
  • Richmond PA, van der Kloet F, Vaz FM, et al. Multi-Omic Approach to Identify Phenotypic Modifiers Underlying Cerebral Demyelination in X-Linked Adrenoleukodystrophy. Front Cell Dev Biol. 2020 Jun 25;8:520. doi: 10.3389/fcell.2020.00520. [Google Scholar]
  • Wang T, Shao W, Huang Z, et al. MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat Commun 12, 3445 (2021). doi: 10.1038/s41467021-23774-w [Google Scholar]
  • Tawbeh A, Gondcaille C, Saih FE, et al. Impaired peroxisomal beta-oxidation in microglia triggers oxidative stress and impacts neurons and oligodendrocytes. Front Mol Neurosci. 2025 Jan 30;18:1542938. doi: 10.3389/fnmol.2025.1542938. [Google Scholar]
  • Argelaguet R, Arnol D, Bredikhin D, et al. MOFA+: a statistical framework for comprehensive integration of multimodal single-cell data. Genome Biol 21, 111 (2020). doi: 10.1186/s13059-020-02015-1 [Google Scholar]
  • Lin Y, Zhang W, Cao H, Li G, Du W. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data. Genes (Basel). 2020 Aug 4;11(8):888. doi: 10.3390/genes11080888. [Google Scholar]
  • Oliveira S, Topsakal O, Toker O. Benchmarking Automated Machine Learning (AutoML) Frameworks for Object Detection. Information 15(1):63 (2024). doi: 10.3390/info15010063 [Google Scholar]
  • Zhou G, Xia J. OmicsNet: a web-based tool for creation and visual analysis of biological networks in 3D space. Nucleic Acids Res. 2018 Jul 2;46(W1):W514–W522. doi: 10.1093/nar/gky510. [Google Scholar]
  • Dou B, Zhu Z, Merkurjev E, et al. Machine Learning Methods for Small Data Challenges in Molecular Science. Chem Rev. 2023 Jul 12;123(13):8736–8780. doi: 10.1021/acs.chemrev.3c00189. [Google Scholar]
  • Cortial L, Montero V, Tourlet S, Del Bano J, Blin O. Artificial intelligence in drug repurposing for rare diseases: a mini-review. Front Med (Lausanne). 2024 May 22;11:1404338. doi: 10.3389/fmed.2024.1404338. [Google Scholar]
  • Coghlan S, Gyngell C, Vears DF. Ethics of artificial intelligence in prenatal and pediatric genomic medicine. J Community Genet. 2024 Feb;15(1):13–24. doi: 10.1007/s12687-023-00678-4. [Google Scholar]
  • Abdallah S, Sharifa M, Almadhoun MKI, et al. The Impact of Artificial Intelligence on Optimizing Diagnosis and Treatment Plans for Rare Genetic Disorders. Cureus. 2023 Oct 11;15(10):e46860. doi: 10.7759/cureus.46860. [Google Scholar]
  • Perez K, Wisniewski D, Ari A, et al. Investigation into Application of AI and Telemedicine in Rural Communities: A Systematic Literature Review. Healthcare (Basel). 2025 Feb 4;13(3):324. doi: 10.3390/healthcare13030324. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.